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C2C12 myoblastAccumulating evidence suggests that caspase-3-mediated cleavage of protein kinase could be a key
event to regulate cell differentiation. In this study, we investigated the role of Nek5 kinase, identi-
ﬁed as a novel substrate for caspase-3, in skeletal muscle differentiation. Up-regulation of Nek5
mRNA expression was accompanied by cell differentiation. Myotube formation was promoted in
Nek5 expressing cells, and was conversely inhibited in Nek5 knockdown cells. Furthermore, we
found that caspase-3 activity, an important factor for myogenic differentiation, was enhanced by
Nek5 cleavage. Although caspase-3-cleaved Nek5 partially exerted a promyogenic effect, it tended
to induce apoptotic cell death. In summary, our ﬁndings suggest that Nek5 promotes myogenic dif-
ferentiation through up-regulation of caspase activity.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Controlling the myogenic differentiation is an essential task for
embryonic muscle development and homeostasis of muscle tissue
in post-developmental stage. Myogenesis is a multistep process, in
which proliferating mononucleated myoblasts withdraw from the
cell cycle, followed by differentiation into myocytes and fusion into
multinucleated myotubes to form functional muscle ﬁbers [1–3].
The myogenic program is regulated by sequential activation of
myogenic regulatory factors (MRFs), the basic helix–loop–helix
(bHLH) family of transcription factors (Myf5, MyoD, myogenin
and MRF4), which can induce expression of muscle-speciﬁc genes
in concert with transcriptional cofactors, MEF2 and E proteins
[4–8].
Apoptosis, a physiological process of programmed cell death,
plays a crucial role in organogenesis during development [9]. Myo-
genic differentiation is actually accompanied by typical apoptotic
signaling events such as caspase-3 activation, and subpopulation
of myoblasts undergoes developmental apoptosis [10]. Caspase-3
activation leads to not only apoptosis but also a non-apoptoticprocess of differentiation [11]. Although the mechanism by which
caspase-3 promotes differentiation is still unclear, several studies
have suggested that the effects produced by caspase-dependent
cleavage of selected substrates, especially some protein kinases
(such as MST1 and HPK1), are required for the regulation of differ-
entiation [10,12–14]. It is noteworthy that active MST1 mediated
by caspase-3 partially overcomes the resistance to the skeletal
muscle differentiation of caspase-3 null myoblasts [10]. Activation
of Rho-kinase, a caspase-targeted kinase, is also required for myo-
genesis [15]. However, regardless of the caspase involvement, ki-
nases play signiﬁcant roles in myogenesis. For example, ERK5
regulates the process of cell fusion in skeletal muscle differentia-
tion through Klf transcription factors, independently of the activi-
ties of MyoD and MEF2 family transcription factors [16]. Other
reports have shown that p38 MAPK induces skeletal muscle gene
expression by activating MRFs and MEF2 transcriptional activities,
and chromatin remodeling activities on muscle-speciﬁc promoters
[17].
We previously identiﬁed 30 protein kinases as novel substrates
for caspase-3 [18], and investigated the role of them in skeletal
muscle differentiation. Nek5, a newly identiﬁed caspase-3 sub-
strate, belongs to the NIMA (never in mitosis A)-related kinase
(Nek) family that is involved in cell cycle regulation. Its function,
however, remains to be deﬁned [19]. In this report, we demon-
strate that Nek5 is involved in the promotion of myogenic differen-
tiation by up-regulating the caspase activity.
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2.1. Reagents and antibodies
Tumor necrosis factor-a (TNFa) (Calbiochem, La Jolla, CA) was
used together with cycloheximide (CHX) (Chemicon, Temecula, CA)
to induce apoptosis. The broad-spectrum caspase inhibitor Z-VAD-
FMK (Peptide Institute Inc., Osaka, Japan) or the reversible inhibitor
of caspase-3/7, 5-[(S)-(+)2-(methoxymethyl)pyrrolidino]sulfonylisat-
in (Calbiochem) was supplemented with TNFa/CHX. Antibodies
against the following antigens were used: myosin heavy chain
(MHC) (clone MF20, Developmental Studies Hybridoma Bank, Iowa
City, IA), troponin C (Santa Cruz Biotechnology, Santa Cruz, CA), GFP
(clone 1E4, Medical & Biological Laboratories Co, Ltd., Nagoya, Japan),
V5 epitope (Invitrogen, Carlsbad, CA), a-tubulin (clone DM1A, Sigma,
St. Louis, MO), FLAG epitope (clone M2, Sigma), cleaved caspase-3
(clone 5A1E, Cell Signaling Technology, Beverly, MA) and cleaved
PARP (Cell Signaling Technology). Alexa Fluor 488-conjugated strep-
tavidin was purchased from Invitrogen.
2.2. Plasmid constructs
To construct expression plasmid for mammalian cells, cDNAs
encoding human MyoD1 (RefSeq: NM_002478), mouse Nek5 (Ref-
Seq: NM_177898) and mouse Nek2 (RefSeq: NM_010892) were
subcloned into suitable vectors from pcDNA series (pcDNA3.1/
nV5-DEST, pcDNA3.2/V5-DEST, pcDNA6.2/N-EmGFP-DEST and
pcDNA6.2/C-EmGFP-DEST) (Invitrogen) by recombination using
Gateway system. A point mutant of Nek5 (serine 438 to aspartic
acid, i.e., D438A) was generated by site-directed mutagenesis using
a PrimeSTAR mutagenesis basal kit (Takara Bio Inc., Otsu, Japan).
For knockdown analysis, RNA interference (RNAi) was performed
using pcDNA6.2-GW/EmGFP-miR expression vector (Invitrogen)
that enables to identify artiﬁcial microRNA (miR) expressing cells
by co-cistronic expression of EmGFP. The following sequences
were selected as RNAi targets: 50-CCAATATCGTAACCTTCTTCA-30
(miR-Nek5-#1), 50-GGGTTTCTTTCAGGATGTCAT-30 (miR-Nek5-#2)
and 50-CCTGGCTAGTGTCATTTCAAA-30 (miR-Nek2) corresponding
to the nucleotide sequences in the coding regions of Nek5 and
Nek2, respectively. The pcDNA6.2-GW/EmGFP-miR-neg control
plasmid (Invitrogen) containing a non-target sequence was used
as a negative control (miR-NC).
2.3. Cell culture and transfection
C2/4 [20], a subclone of the C2C12 mouse myoblast cell line, was
referred to simply as C2C12 in this paper. C2C12 cells and HeLa cells
were maintained at 37 C in a 5% CO2 incubator in a growth medium
(GM) of Dulbecco’s modiﬁed eagle medium (DMEM) (Nissui, Tokyo,
Japan) supplemented with 10% fetal bovine serum (Sigma), 2 mM L-
glutamine (GIBCO, Grand Island, NY), and antibiotics (100 units/ml
penicillin and 100 lg/ml streptomycin) (GIBCO). Myogenic differenti-
ation of C2C12 myoblasts was induced by replacing the GM with a
differentiation medium (DM) that is DMEMwith high glucose (Wako,
Osaka, Japan) supplemented with 2% horse serum and penicillin–
streptomycin. Unless otherwise noted, cells were cultured in GM.
All transfections in this study, except for the experiment in Fig. 4A
(Lipofectamine 2000, Invitrogen), were performed using the Tran-
sIT-LT1 transfection reagent (Mirus, Madison, WI) according to the
manufacturer’s instruction.
2.4. Western blot analysis
All Western blot analyses were performed as described previ-
ously [21]. Brieﬂy, proteins in whole-cell lysates were separatedby SDS–PAGE and transferred onto a PVDF membrane by electro-
blotting. After blocking with 5% milk/TBST, the membrane was
probed with a given primary antibody and then incubated with a
horseradish peroxidase (HRP)-conjugated secondary antibody.
The immunoreactive proteins were visualized using Immobilon
Western HRP substrate Luminol Reagent (Millipore, Bedford, MA)
and LAS-4000 mini biomolecular imager (GE Healthcare, Piscata-
way, NJ).
2.5. Immunostaining analysis
Cells were ﬁxed with 4% paraformaldehyde in phosphate-buf-
fered saline (PBS) for 15 min at room temperature, and then per-
meabilized with 0.5% Triton X-100 in PBS for 5 min. After
blocking with 5% calf serum in TBST for 1 h, the cells were incu-
bated with anti-troponin C antibody, anti-MHC antibody or anti-
cleaved caspase-3 antibody for 1 h at 37 C. The cells were then
incubated with Alexa Fluor 555-conjugated appropriate secondary
antibody (Invitrogen) for 1 h at room temperature. Fluorescence
images were acquired by the Carl Zeiss LSM710 confocal laser
scanning microscope (Carl Zeiss, Jena, Germany).
2.6. Real-time quantitative RT-PCR analysis
Total cellular RNA was extracted from C2C12 cells using a QIA-
easy RNA mini kit (Qiagen, Valencia, CA). Extracted total RNA was
subjected to reverse transcription with a Transcriptor First Strand
cDNA Synthesis Kit (Roche, Basel, Schweiz). The real-time qRT-
PCR analysis was performed using a LightCycler 480 Real-time
PCR System (Roche). The following primer set for Nek5 was
designed by the software of Assay Design Center (Roche):
50-GGAAGAACAAAATGAAGGACCA-30 (forward) and 50-CTTCATGT-
CGTTGTGGTACTGTT-30 (reverse). The values were normalized to
GAPDH (primer set was purchased from Roche).
2.7. Cell-free protein synthesis and in vitro cleavage assay
Construction of DNA template and cell-free transcription/trans-
lation for Nek5 were performed as described previously [18].
Cleavage reaction of the synthesized Nek5 by caspase was also car-
ried out following the method described previously [21].
2.8. Luminometric detection of caspase-3/7 activity
Caspase-3/7 activity was measured by using the luminometric
Caspase-Glo 3/7 Assay kit (Promega, Madison, WI) and a GloM-
axTM 96 Microplate Luminometer (Promega) according to the
manufacturer’s instructions.
2.9. Statistical analysis
Data shown are mean ± S.D. Student’s t-test was used to deter-
mine the signiﬁcance of differences. P values of less than 0.05 were
considered statistically signiﬁcant.
3. Results
3.1. Nek5 is a novel substrate for caspase-3
We previously reported a high-throughput protease substrate
screening method by which 30 kinases were identiﬁed as novel
substrates for caspase-3 [18]. Here, using the same method, we
identiﬁed Nek5 as a substrate for caspase-3, but not caspase-6, -
7 and -8 (Fig. 1A). Caspase-3 prefers an Asp residue at both P1
and P4 positions in DXXD motif for proteolytic cleavage [22].
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tential cleavage site was speculated at Asp438/Arg439 from the
molecular weight of the cleaved fragment as estimated by Western
blot analysis (Fig. 1A, arrowheads, and Fig. 1B). To precisely deter-
mine the cleavage site, we constructed mutants of Nek5 as shown
in Fig. 1B: alanine point mutant (D438A) and deletion mutant
(DC176, amino acids 1–438). In vitro cleavage assay revealed that
D438A-Nek5 and DC176-Nek5 were not cleaved by caspase-3,
whereas wild type Nek5 (WT) was cleaved (Fig. 1C). Additionally,
the size of cleaved fragment derived from WT-Nek5 was almost
the same with that of DC176-Nek5. A similar result was obtained
in apoptotic HeLa cells (Fig. 1D). An increase in the amount of
cleaved fragment was observed in apoptosis induction using
TNFa/CHX, and both the pan-caspase inhibitor Z-VAD-FMK and
caspase-3/7 inhibitor completely blocked it (Fig. 1D and E). These
results clearly indicate that Nek5 is cleaved at Asp438 by cas-
pase-3 during the apoptotic process.
3.2. Nek5 promotes myogenic differentiation of C2C12 myoblasts
Accumulating evidence suggests that protein kinases as sub-
strates for caspase-3 play a signiﬁcant role in regulation of differ-
entiation [10,11,13]. To investigate the possible role of Nek5 in
myogenic differentiation, Nek5 was transiently overexpressed in
C2C12myoblasts. The expression levels of the twomyogenic mark-
ers: MHC and troponin C, were increased by Nek5 expression com-
pared to EGFP-V5 (transfection control) (Fig. 2A). A muscle-speciﬁc
regulator MyoD1 is known to induce myogenesis in numerous cellFig. 1. Nek5 is cleaved by caspase-3 in vitro and in apoptotic cells. (A) N-terminal FLAG
wheat cell-free expression system. Nek5 was incubated in the presence or absence of indi
(upper panel) and Alexa 488-conjugated streptavidin (lower panel), which bound to
(B) Schematic diagram of Nek5 constructs used in this study and the cleavage site for casp
deletion mutant containing the kinase domain (amino acids 1–438); and DN438, deletion
free expression system was incubated in the presence or absence of caspase-3, and then d
cells with the indicated V5-tagged Nek5 expression plasmid, cells were treated with TNF
4 h. Cell lysates were subjected to Western blot analysis using anti-V5, anti-cleaved P
reversible inhibitor of caspase-3/7, 5-[(S)-(+)2-(methoxymethyl)pyrrolidino]sulfonylisattypes including C2C12 cells [23]. Immunostaining showed that
large myotubes were formed in cells expressing Nek5 (Fig. 2B).
Furthermore, Nek5 was mostly expressed in the differentiated cells
that were positive for MHC expression, and was hardly found in
myoblasts negative for MHC, as is the case with MyoD1 (Fig. 2C).
These results indicate that Nek5 is able to promote myogenic
differentiation.
3.3. Up-regulation of Nek5 expression during differentiation
contributes to the promyogenic effect
To investigate whether Nek5 expression is induced during myo-
genic differentiation, we monitored the expression levels of Nek5
mRNA. The induction of differentiation in C2C12 cells by DM re-
sulted in a transient increase in the expression of Nek5 mRNA
(Fig. 3A). A signiﬁcant increase in Nek5 mRNA was observed in
C2C12 cells cultured in GM on day 4 (Fig. 3A, right panel), which
was consistent with the timing of a dramatic increase in the
expression of MHC protein (Fig. 3B). These results suggest that
myogenic differentiation is accompanied by up-regulation of
Nek5. Next, to examine whether Nek5 expression is required for
the progression of myogenic differentiation, we constructed vec-
tors expressing microRNAs (miRNA) targeting Nek5 (miR-Nek5-
#1 andmiR-Nek5-#2). These miRNAs speciﬁcally suppressed exog-
enous Nek5 expression (Supplementary Fig. S1). However, due to
the unavailability of a speciﬁc antibody and/or the signiﬁcantly
low expression of Nek5 protein, we could not conclude that
whether or not the expression of endogenous Nek5 is down-regu-tagged and C-terminal biotinylated Nek5 (FLAG-Nek5-bls) was synthesized by the
cated caspase and the cleavage product was then detected using anti-FLAG antibody
the N- and C-termini, respectively. Arrowheads indicate the cleaved fragments.
ase-3. WT, wild type Nek5; D438A, caspase-3 cleavage-site mutant of Nek5; DC176,
mutant (amino acids 439–614). (C) Each FLAG-Nek5 synthesized by the wheat cell-
etected using anti-FLAG antibody. (D) Twenty-four hours after transfection of HeLa
a (20 ng/ml)/CHX (100 lM) in the presence or absence of Z-VAD-FMK (100 lM) for
ARP (apoptosis marker) and anti-a-tubulin (internal control) antibodies. (E) The
in (100 lM) was used as in Fig. 1D.
Fig. 2. Nek5 exerts a promyogenic effect. C2C12 cells were transfected with the indicated expression vectors. (A) After 3 days of transfection, cell lysate were subjected to
Western blot analysis using anti-MHC, anti-troponin C, and anti-V5 antibodies, respectively. (B) After 6 days of transfection, differentiated cells were detected by
immunostaining with anti-troponin C antibody (red). Scale bars = 200 lm. (C) Differentiated cells were immunostained with anti-MHC antibody after 4 days of transfection,
and then quantiﬁed for the percentage of that in cells expressing the indicated proteins. Error bars indicate S.D. (N = 4, each N consists of 150 < cells). A P value < 0.05 was
accepted as signiﬁcant.
Fig. 3. The mRNA encoding Nek5 is up-regulated during myogenic differentiation. (A and B) Semi-conﬂuent C2C12 cells were cultured in GM or DM for indicated days, and
then collected. (A) The relative expression levels of Nek5 mRNA were determined by real-time quantitative RT-PCR. GAPDH mRNA was used as an internal control. Error bars
indicate S.D. (N = 3). ⁄P < 0.001, ⁄⁄P < 0.005, statistically signiﬁcant difference. N.S., not signiﬁcant. (B) Cell lysates were subjected to Western blot analysis using anti-MHC
antibody. The relative expression levels of MHC protein were quantiﬁed using ImageJ software. a-tubulin was used for normalization. (C, D) C2C12 cells were transfected with
the indicated artiﬁcial miRNA expression plasmids. (C) After 6 days of transfection, differentiated cells were detected by immunostaining with anti-troponin C antibody (red).
Scale bars = 200 lm. (D) Differentiated cells were immunostained with anti-MHC antibody after 4 days of transfection, and then quantiﬁed for the percentage of that in
miRNA-expressing cells of inner panel visualized by co-cistronic expression of EmGFP. Error bars indicate S.D. (N = 4, each N consists of 150 < cells).
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expressing cells by co-cistronic expression of EmGFP. Among them,
a population of troponin C negative regarded as undifferentiated
cells was frequently observed in cells suppressing Nek5 expressioncompared with non-target negative control miRNA (miR-NC) and
Nek2 (miR-Nek2) (Fig. 3C). To further conﬁrm it, percentage of dif-
ferentiated cells expressing miRNA was quantiﬁed by MHC stain-
ing, and the results showed that the percentage was decreased in
Fig. 4. Nek5 regulates caspase-3 activity during myogenic differentiation. (A) Twenty-four hours after transfection, C2C12 cells were further cultured in fresh GM or DM for
1 day or 2 days. The cell lysates were subjected to Western blot analysis using anti-V5 and anti-a-tubulin antibodies. Arrowhead indicates the location of cleaved fragments.
(B) HeLa cells were cultured for 2 days after transfection, and then caspase-3/7 activity was measured. Error bars indicate S.D. (N = 3). (C) Thirty hours after transfection, HeLa
cells were immunostained with anti-cleaved caspase-3 antibody and counterstained with DAPI to visualize the nuclei. Apoptotic cells were counted among cells expressing
the indicated proteins. Cells fulﬁlling all of the following features were deﬁned as apoptotic cells: cleaved caspase-3 positive, cell shrinkage and nuclear condensation and/or
fragmentation. Error bars indicate S.D. (N = 3, each N consists of 200 < cells). (D) Apoptotic C2C12 cells were counted as in Fig. 4C without immunoﬂuorescent staining of
cleaved caspase-3. Error bars indicate S.D. (N = 3, each N consists of 100 < cells). (E and F) After 3 days of transfection, C2C12 cells were collected. Cell lysates were subjected
to Western blot analysis (E) and luminometric assay (F) to detect caspase-3 activity. Error bars indicate S.D. (N = 4). (G) After 4 days of transfection, C2C12 cells were stained
with DAPI (blue, left panel) to count nuclei of cells expressing the indicated proteins (green, left panel). The number of nuclei was grouped into four categories (1, 2–8, 9–15,
15<), and the percentage of that was quantiﬁed (right panel). Error bars indicate S.D. (N = 3, each N consists of 100 < cells).
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suggest that Nek5 expression contributes to the progression of
myogenic differentiation.
3.4. Nek5 is involved in the regulation of caspase-3 activity during
myogenic differentiation
Previous studies have suggested that caspase-mediated cleav-
age of kinase could be a key signal for regulation of cell differenti-
ation [10,12–14]. For example, caspase-3-dependent activation of
MST1 brings about promyogenic effect as well as apoptosis [10].
In this study, we demonstrated that Nek5 is a substrate for cas-
pase-3 as show in Fig. 1. Since activation of caspase-3 is known
to be associated with myogenic differentiation, we tested whether
the cleavage of Nek5 indeed occurs during the differentiation
process. In WT-Nek5, instead of D438A mutant that is resistant
to proteolytic cleavage by caspase-3, a remarkable reduction of
full-length Nek5 and the appearance of the cleaved fragment were
clearly observed on Day1 but not Day2 by replacing the GM with
DM (Fig. 4A). This is likely to be the result of caspase-3 activity that
is transiently increased and reaches the peak level within 24 h after
induction of myogenic differentiation in C2C12 myoblasts [10].
Thus, this result suggests that the physiological processing ofNek5 occurs in the early phase of myogenic differentiation. We
next asked whether the cleavage of Nek5 has some implications
for myogenesis. The large fragment of Nek5 (DC176-Nek5) pro-
duced by caspase-3 contains the kinase domain, which is raising
the possibility that the kinase activity of Nek5 is modulated by
the cleavage, as is the case for MST1 [10]. To address this possibil-
ity, a conventional kinase assay using histone H1 and myelin basic
protein as substrates was performed. However, no difference in the
kinase activity was found between full-length Nek5 and the
cleaved fragment (data not shown). Nevertheless, caspase-3-med-
iated cleavage of substrates is often linked to the pro-apoptotic ef-
fect [24]. Therefore, to test whether the cleaved fragment of Nek5
can exert pro-apoptotic effect, caspase-3/7 activity was measured
in HeLa cells expressing DC176-Nek5. As shown in Fig. 4B, increase
in the caspase-3/7 activity was observed in cells expressing
DC176-Nek5. Interestingly, WT-Nek5 and D438A-Nek5 also ex-
erted the pro-apoptotic effect compared with EGFP-V5 as a control
(Fig. 4B). As expected, these levels of caspase-3/7 activity were cor-
related with the number of apoptotic cells (Fig. 4C and D). More-
over, to verify whether Nek5 was involved in the activation of
caspase-3 during myogenic differentiation, knockdown of Nek5
expression was performed in C2C12 myoblasts. In consequence
of that, caspase-3 activation was partially inhibited in cells
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est inhibition is due to low transfection efﬁciency of miRNA
expression plasmids. Alternatively, in order to get the maximal ef-
fect of Nek5 knockdown, myogenic differentiation was induced in
DM instead of GM, and then caspase-3 activity was detected at the
time point of caspase-3 activity peak. But, unexpectedly, the effect
was more modest. This may be the result of a drastic increase in
caspase-3 activity, which negates the effect of Nek5 knockdown.
Thus, these results suggest that the cleavage of Nek5 enhances
the pro-apoptotic effect of Nek5 in the process of myogenic differ-
entiation. In the last analysis, to assess how the Nek5-dependent
regulation of caspase activity affects myogenic differentiation,
the degree of differentiation in cells expressing WT-Nek5 and its
mutants was estimated and compared by counting the number
of nuclei in C2C12 myotubes. In any case, each Nek5 serves as a po-
sitive regulator for the progression of myogenic differentiation
compared with control (Fig. 4G). However, large myotubes (more
than 15 nuclei) were not observed in cells expressing DC176-
Nek5 so many as the case of WT-Nek5 and D438A-Nek5. This result
is consistent with the relative expression levels of MHC (Supple-
mentary Fig. S2). Taken together, these ﬁndings suggest a possibil-
ity that the level of caspase activity due to DC176-Nek5
preferentially leads to apoptosis rather than promyogenic effect.
Therefore, Nek5 may contribute to the ﬁne-tuning of caspase activ-
ity suitable for myogenesis.
4. Discussion
Studies in the last decade or so have demonstrated that mam-
malian Nek kinases mainly function as cell cycle regulators. How-
ever, function of Nek5 remains unknown. In this study, we present
evidence that Nek5 is involved in myogenic differentiation by con-
trolling caspase-3 activity.
The regulation of caspase-3 activity is capable of realizing the
non-apoptotic outcomes, such as a departure from self-renewing
state of embryonic stem cells or progenitor (i.e., differentiation)
[25], and nuclear reprogramming in iPS cells induction (i.e., dedif-
ferentiation) [26]. Defects in these processes including myogenic
differentiation were observed in cells lacking caspase-3 or under
inhibitory conditions of caspase-3 activity due to the biological
and chemical barrier [10,27]. As regards the role of caspase-3 sig-
naling in cell differentiation, Larsen’s study showed the possibility
that caspase-3/caspase-activated DNase (CAD)-dependent DNA
strand breaks promote cell differentiation by modifying the DNA/
nuclear microenvironment to regulate gene expression, such as
p21 [28]. Furthermore, Fernando and Arnold demonstrated that
caspase-3-dependent activation of MST1 and HPK1 kinases medi-
ates pro-apoptotic and pro-survival signaling, respectively, which
contributes to progression of differentiation [10,13].
As shown in Figs. 1 and 4, our data revealed that Nek5 is a sub-
strate for caspase-3 and is able to exert pro-apoptotic and promy-
ogenic effects. Although the mechanism by which pro-apoptotic
effect of Nek5 was produced remains unclear, caspase-3-mediated
cleavage would enhance it. However, it seems that not all of the
processing accelerates myogenesis, because the promyogenic ef-
fect of DC176-Nek5 was lower than WT-Nek5 and D438A-Nek5
(Fig. 4G and Supplementary Fig. S2). Additionally, the promyogenic
effect was not observed in cells expressing DN438-Nek5 (amino
acids 439–614, see Fig. 1B). Alternatively, we have eliminated the
possibility that the promyogenic effect is dependent on kinase
activity, since no difference was observed between WT-Nek5 and
DC176-Nek5 (data not shown). Recently, Nakanishi et al. proposed
that ER stress exerts a positive effect on myoﬁber formation by
eliminating vulnerable cells to make a resistant cell population
that are competent to efﬁciently fuse with one another, and/ordrawing the potential for differentiation from myoblasts [29]. In
murine models, ER stress-induced apoptosis but not by mem-
brane- or mitochondrial-targeted apoptotic signals was speciﬁcally
mediated by caspase-12 [30]. Under conditions of myogenic differ-
entiation, in fact, caspase-12 was activated by ER stress [31]. Taken
together with above reports, our ﬁndings indicate that Nek5 con-
tributes to the ﬁne-tuning of caspase activity to realize the suitable
environment for myogenesis.
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